Evidence for axonal pathology and adaptive cortical reorganization in patients at presentation with clinically isolated syndromes suggestive of multiple sclerosis

NeuroImage

Volumn 18, Issue 4, 2003, Pages 847-855

  Rocca, Maria A ^a   Mezzapesa, Domenico M ^a   Falini, Andrea ^a   Ghezzi, Angelo ^b   Martinelli, Vittorio ^a   Scotti, Giuseppe ^a   Comi, Giancarlo ^a   Filippi, Massimo ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b Multiple Sclerosis Center   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

N ACETYLASPARTIC ACID;

ADAPTATION; ADULT; ARTICLE; AXONAL INJURY; BRAIN; BRAIN CORTEX; BRAIN FUNCTION; CLINICAL ARTICLE; CONTROLLED STUDY; ELECTROENCEPHALOGRAM; EVIDENCE BASED MEDICINE; FEMALE; FINGER; HUMAN; MALE; MOTOR CORTEX; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; RIGHT HANDEDNESS; SOMATOSENSORY CORTEX; SYNDROME; TISSUE INJURY;

EID: 0037398201     PISSN: 10538119     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1053-8119(03)00043-0     Document Type: Article

References (53)

1. Binkofski F., Buccino G., Posse S., et al. A fronto-parietal circuit for object manipulation in man evidence from an fMRI-study . Eur. J. Neurosci. 11:1999;3276-3286.
2. Brex P.A., Ciccarelli O., O'Riordan J.I., et al. A longitudinal study of abnormalities on MRI and disability from multiple sclerosis. N. Engl. J. Med. 346:2002;158-164.
3. Brex P.A., Gomez-Anson B., Parker G.J., et al. Proton MR spectroscopy in clinically isolated syndromes suggestive of multiple sclerosis. J. Neurol. Sci. 166:1999;16-22.
4. Brex P.A., Jenkins R., Fox N.C., et al. Detection of ventricular enlargement in patients at the earliest clinical stage of MS. Neurology. 54:2000;1689-1691.
5. Brex P.A., Leary S.M., Plant G.T., et al. Magnetization transfer imaging in patients with clinically isolated syndromes suggestive of multiple sclerosis. Am. J. Neuroradiol. 22:2001;947-951.
6. Chard D.T., Griffin C.M., Parker G.J., et al. Brain atrophy in clinically early relapsing-remitting multiple sclerosis. Brain. 125:2002;327-337.
7. Davie C.A., Hawkins C.P., Barker G.J., et al. Serial proton magnetic resonance spectroscopy in acute multiple sclerosis lesions. Brain. 117:1994;49-58.
8. De Stefano N., Matthews P.M., Antel J.P., et al. Chemical pathology of acute demyelinating lesions and its correlation with disability. Ann. Neurol. 38:1995;901-909.
9. De Stefano N., Matthews P.M., Filippi M., et al. Evidence of early cortical gray matter atrophy in patients with relapsing-remitting and primary progressive multiple sclerosis. Neurology. 58:(Suppl.3):2002;S67.003.
10. De Stefano N., Narayanan S., Francis G.S., et al. Evidence of axonal damage in the early stages of multiple sclerosis and its relevance to disability. Arch. Neurol. 58:2001;65-70.
11. De Stefano N., Narayanan S., Matthews P.M., et al. In vivo evidence for axonal dysfunction remote from focal cerebral demyelination of the type seen in multiple sclerosis. Brain. 122:1999;1933-1939.
12. Disbrow E., Roberts T., Krubitzer L. Somatotopic organization of cortical fields in the lateral sulcus of Homo sapiens evidence for SII and PV . J. Comp. Neurol. 418:2000;1-21.
13. Evangelou N., Konz D., Esiri M.M., et al. Regional axonal loss in the corpus callosum correlates with cerebral white matter lesion volume and distribution in multiple sclerosis. Brain. 123:2000;1845-1849.
14. Filippi M., Inglese M., Rovaris M., et al. Magnetization transfer imaging to monitor the evolution of MS a 1-year follow-up study . Neurology. 55:2000;940-946.
15. Filippi M., Rocca M.A., Falini A., et al. Correlations between structural CNS damage and functional MRI changes in primary progressive MS. NeuroImage. 15:2002;537-546.
16. Filippi M., Rovaris M., Capra R., et al. A multi-centre longitudinal study comparing the sensitivity of monthly MRI after standard and triple dose gadolinium-DTPA for monitoring disease activity in multiple sclerosis. Implications for phase II clinical trials. Brain. 121:1998;2011-2020.
17. Fink G.R., Frackowiak R.S., Pietrzyk U., Passingham R.E. Multiple nonprimary motor areas in the human cortex. J. Neurophysiol. 77:1997;2164-2174.
18. Friston K.J., Holmes A.P., Poline J.B., et al. Analysis of fMRI time-series revisited. NeuroImage. 2:1995;45-53.
19. Friston K.J., Holmes A.P., Price C.J., et al. Multisubject fMRI studies and conjunction analyses. NeuroImage. 10:1999;385-396.
20. Ge Y., Grossman R.I., Udupa J.K., et al. Brain atrophy in relapsing-remitting multiple sclerosis fractional volumetric analysis of gray matter and white matter . Radiology. 220:2001;606-610.
21. Gonen O., Catalaa I., Babb J.S., et al. Total brain N-acetylaspartate a new measure of disease load in MS . Neurology. 54:2000;15-19.
22. Gonen O., Viswanathan A.K., Catalaa I., et al. Total brain N-acetylaspartate concentration in normal, age-grouped females quantitation with non-echo proton NMR spectroscopy . Magn. Reson. Med. 40:1998;684-689.
23. Hamalainen H., Hiltunen J., Titievskaja I. fMRI activations of SI and SII cortices during tactile stimulation depend on attention. Neuroreport. 11:2000;1673-1676.
24. Harrington D.L., Rao S.M., Haaland K.Y., et al. Specialized neural systems underlying representations of sequential movements. J. Cogn. Neurosci. 12:2000;56-77.
25. Haslinger B., Erhard P., Weilke F., et al. The role of lateral premotor-cerebellar-parietal circuits in motor sequence control a parametric fMRI study . Brain Res. Cogn. Brain Res. 13:2002;159-168.
26. Herndon R.M. Handbook of Neurologic Rating Scales. 1997;Demos Vermande, New York.
27. Iannucci G., Tortorella C., Rovaris M., et al. Prognostic value of MR and magnetization transfer imaging findings in patients with clinically isolated syndromes suggestive of multiple sclerosis at presentation. Am. J. Neuroradiol. 21:2000;034-1038.
28. Jeannerod M., Frak V. Mental imaging of motor activity in humans. Curr. Opin. Neurobiol. 9:1999;735-739.
29. Kaiser J.S., Grossman R.I., Polansky M., et al. Magnetization transfer histogram analysis of monosymptomatic episodes of neurologic dysfunction preliminary findings . Am. J. Neuroradiol. 21:2000;1043-1047.
30. Kapeller P., McLean M.A., Griffin C.M., et al. Preliminary evidence for neuronal damage in cortical grey matter and normal appearing white matter in short duration relapsing-remitting multiple sclerosis a quantitative MR spectroscopic imaging study . J. Neurol. 248:2001;131-138.
31. Karhu J., Tesche C.D. Simultaneous early processing of sensory input in human primary (SI) and secondary (SII) somatosensory cortices. J. Neurophysiol. 81:1999;2017-2025.
32. Kurtzke J.F. Rating neurological impairment in multiple sclerosis en expanded disability status scale (EDSS) . Neurology. 33:1983;1444-1452.
33. Lassmann H., Brück W., Lucchinetti C., Rodriguez M. Remyelination in multiple sclerosis. Mult. Scler. 3:1997;133-136.
34. Lee M., Reddy H., Johansen-Berg H., et al. The motor cortex shows adaptive functional changes to brain injury from multiple sclerosis. Ann. Neurol. 47:2000;606-613.
35. Martino A.M., Strick P.L. Corticospinal projections originate from the arcuate premotor area. Brain Res. 404:1987;307-312.
36. McDonald W.I., Compston A., Edan G., et al. Recommended diagnostic criteria for multiple sclerosis guidelines from the International Panel on the diagnosis of multiple sclerosis . Ann. Neurol. 50:2001;21-127.
37. Miller D.H., Barkhof F., Berry I., et al. Magnetic resonance imaging in monitoring the treatment of multiple sclerosis Concerted action guidelines . J. Neurol. Neurosurg. Psychiatry. 54:1991;83-688.
38. Narayana P.A., Doyle T.J., Lai D., Wolinsky J.S. Serial proton magnetic resonance spectroscopic imaging, contrast-enhanced magnetic resonance imaging, and quantitative lesion volumetry in multiple sclerosis. Ann. Neurol. 43:1998;6-71.
39. Noseworthy J.H., Lucchinetti C., Rodriguez M., Weinshenker B.G. Multiple sclerosis. N. Engl. J. Med. 343:2000;38-952.
40. Peterson J.W., Bo L., Mork S., et al. Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions. Ann. Neurol. 50:2001;89-400.
41. Poline J.B., Worsley K.J., Evans A.C., Friston K.J. Combining spatial extent and peak intensity to test for activations in functional imaging. NeuroImage. 5:1997;3-96.
42. Reddy H., Narayanan S., Arnoutelis R., et al. Evidence for adaptive functional changes in the cerebral cortex with axonal injury from multiple sclerosis. Brain. 123:2000;314-2320.
43. Rocca M.A., Falini A., Colombo B., et al. Adaptive functional changes in the cerebral cortex of patients with non-disabling MS correlate with the extent of brain structural damage. Ann. Neurol. 51:2002;30-339.
44. Rocca M.A., Matthews P.M., Caputo D., et al. Evidence for widespread movement-associated functional MRI changes in patients with PPMS. Neurology. 58:2002;66-872.
45. Rovaris M., Inglese M., van Schijndel R.A., et al. Sensitivity and reproducibility of volume change measurements of different brain portions on magnetic resonance imaging in patients with multiple sclerosis. J. Neurol. 247:2000;960-965.
46. Rudick R.A., Fisher E., Lee J.C., et al. Use of the brain parenchymal fraction to measure whole brain atrophy in relapsing-remitting MS. Multiple Sclerosis Collaborative Research Group. Neurology. 53:1999;698-704.
47. Simmons M.L., Frondoza C.G., Coyle J.T. Immunocytochemical localization of N-acetyl-aspartate with monoclonal antibodies. Neuroscience. 45:1991;7-45.
48. Stephan K.M., Fink G.R., Passingham R.E., et al. Functional anatomy of the mental representation of upper extremity movements in healthy subjects. J. Neurophysiol. 73:1995;73-386.
49. Traboulsee A., Dehmeshki J., Brex P.A., et al. Normal-appearing brain tissue MTR histograms in clinically isolated syndromes suggestive of MS. Neurology. 59:2002;26-128.
50. Trapp B.D., Peterson J., Ransohoff R.M., et al. Axonal transection in the lesions of multiple sclerosis. N. Engl. J. Med. 338:1998;78-285.
51. van Waesberghe J.H., Kamphorst W., De Groot C.J., et al. Axonal loss in multiple sclerosis lesions magnetic resonance imaging insights into substrates of disability . Ann. Neurol. 46:1999;47-754.
52. Waxman S.G., Ritchie J.M. Molecular dissection of the myelinated axon. Ann. Neurol. 33:1993;21-136.
53. Worsley K.J., Friston K.J. Analysis of fMRI time-series revisited again. NeuroImage. 2:1995;73-181.